Express & Expedited Shipping Service
USD $45.95
IndiaEcosprin Gold 20 is a combination medication that includes Aspirin (75 mg), Atorvastatin (20 mg), and Clopidogrel (75 mg). It is primarily used for the prevention of cardiovascular events such as heart attacks and strokes in individuals at high risk.
This medication is indicated for patients with a history of cardiovascular diseases or those with multiple risk factors. It helps in reducing the risk of heart attacks, strokes, and other cardiovascular complications.
The three active ingredients work synergistically to inhibit platelet aggregation, lower cholesterol levels, and improve overall heart health. Aspirin prevents blood clots, Atorvastatin reduces cholesterol production in the liver, and Clopidogrel further prevents blood clots by inhibiting platelet activation.
It is essential to follow the prescribed dosage by your healthcare provider. Typically, the recommended dosage is one tablet daily, taken with or without food.
Common side effects may include gastrointestinal discomfort, headaches, and dizziness. If you experience any severe side effects or allergic reactions, seek medical attention immediately.
Before taking Ecosprin Gold 20, inform your healthcare provider about any existing medical conditions, allergies, or other medications you are taking. It is not recommended for individuals with certain bleeding disorders or those who are pregnant unless advised by a doctor.
Store at room temperature, away from moisture and heat. Keep out of reach of children.
Q: Can I take Ecosprin Gold 20 with other medications?
A: Always consult your healthcare provider before combining this medication with others to avoid potential interactions.
Q: Is it safe to use during pregnancy?
A: Ecosprin Gold 20 should only be used during pregnancy if clearly needed and prescribed by a healthcare professional.
Q: How long should I take this medication?
A: The duration of treatment will be determined by your doctor based on your condition and response to therapy.
Health Guides
Nov 01, 2026
Baricitinib safety depends on infection screening, blood tests, and prompt evaluation of new symptoms. The main concerns are serious infections, shingles, blood clots, cancer, and cardiovascular events. Blood counts, liver and kidney function, and cholesterol help guide treatment. Historical rheumat
Oct 30, 2026
Tacrolimus monitoring measures the tacrolimus level in whole blood to help balance organ rejection prevention against drug-related toxic effects. The result is useful only when interpreted against the dose and formulation. A routine trough sample is collected immediately before the next dose, usuall
Oct 28, 2026
Lithium monitoring combines timed blood levels with kidney, thyroid, and calcium tests to keep bipolar treatment effective and reduce toxicity risk. Testing starts before treatment and continues throughout it. Lithium has a narrow therapeutic index, so relatively small changes in blood concentration
Oct 23, 2026
Vitamin B12 deficiency can cause anemia, fatigue and nerve damage, but symptoms alone can't confirm the diagnosis. Blood tests help establish whether B12 is low and whether poor intake or impaired absorption explains the result. Early treatment matters because neurological damage can become permanen
Oct 20, 2026
Methimazole for hyperthyroidism reduces excess thyroid hormone production without destroying the thyroid gland. Treatment usually starts with a higher dose, followed by blood-test-guided reductions as hormone levels return to normal. This guide to methimazole hyperthyroidism treatment covers testing
Oct 19, 2026
Atrial fibrillation medications address three goals: rate control for a fast heart rate, rhythm control for an abnormal rhythm, and stroke prevention with anticoagulants that reduce blood clots. For atrial fibrillation, the regimen depends on stroke risk, heart and kidney function, and other prescri
Oct 17, 2026
Heart failure medications reduce strain on the heart, control fluid buildup, and lower the risk of hospitalization. Several drug classes also improve survival in people with reduced ejection fraction, although medicines don't cure heart failure. Treatment usually combines medicines because each addr
Oct 16, 2026
SGLT2 inhibitors lower blood glucose by helping the kidneys remove glucose through urine. Selected medicines also reduce heart-failure events and slow chronic kidney disease progression, so prescribing decisions extend beyond blood sugar alone. The short answer: SGLT2 inhibitors can benefit people
Oct 15, 2026
Potassium salt substitutes can lower sodium intake and blood pressure, but some hypertension medicines make the extra potassium unsafe. The main concern is hyperkalemia, an elevated blood potassium level that can disturb the heart's rhythm. Safety depends on kidney function, the complete medication
Oct 13, 2026
A COPD diagnosis often leads to several prescriptions, each with a different job. A rescue inhaler eases sudden breathing symptoms. Long-acting bronchodilators are taken daily to control breathlessness and reduce exacerbations. Inhaled corticosteroids may be prescribed for people with recurrent fla
